Literature DB >> 7425611

Susceptibility of Legionella pneumophila to twenty antimicrobial agents.

P H Edelstein, R D Meyer.   

Abstract

Thirty-three isolates of Legionella pneumophila, all except one of which were clinical isolates, were tested against 20 antimicrobial agents by using an agar dilution technique. Erythromycin, rifamp]in, and rosaramycin were the most active agents tested. Aminoglycosides, chloramphenicol, and cefoxitin also inhibited the organisms at low concentrations. Other agents, including moxalactam, cefoperazone, and cephalosporins, exhibited moderate to little activity. Tetracycline, doxycycline and minocyeline were apparently inactivated by charcoal-yeast extract medium. There was slight inoculum dependence noted with most of the antimicrobials tested, particularly the beta-lactam agents. There was no consistent difference in susceptibility between Center for Disease Control-supplied stock strains and recent clinical isolates, but there were marked differences with some agents. Susceptibility testing needs to be standardized in view of the influence of inoculum size, strain variation, and the medium used.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7425611      PMCID: PMC284014          DOI: 10.1128/AAC.18.3.403

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Minimal inhibitory concentrations of 34 antimicrobial agents for control strains Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853.

Authors:  R J Fass; J Barnishan
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

2.  Use of a semiselective medium to culture Legionella pneumophila from contaminated lung specimens.

Authors:  P H Edelstein; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-08       Impact factor: 5.948

3.  Isolation of a new serotype of legionnaires' disease bacterium.

Authors:  P H Edelstein; R D Meyer; S M Finegold
Journal:  Lancet       Date:  1978-12-02       Impact factor: 79.321

4.  Isolation of Legionella pneumophila from blood.

Authors:  P H Edelstein; R D Meyer; S M Finegold
Journal:  Lancet       Date:  1979-04-07       Impact factor: 79.321

5.  The rickettsia-like organisms TATLOCK (1943) and HEBA (1959): bacteria phenotypically similar to but genetically distinct from Legionella pneumophila and the WIGA bacterium.

Authors:  G A Hébert; C W Moss; L K McDougal; F M Bozeman; R M McKinney; D J Brenner
Journal:  Ann Intern Med       Date:  1980-01       Impact factor: 25.391

6.  Inactivation of beta-lactam antibiotics by Legionella pneumophila.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

7.  In vitro activity of antimicrobial agents on Legionnaires disease bacterium.

Authors:  C Thornsberry; C N Baker; L A Kirven
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

8.  Charcoal-yeast extract agar: primary isolation medium for Legionella pneumophila.

Authors:  J C Feeley; R J Gibson; G W Gorman; N C Langford; J K Rasheed; D C Mackel; W B Baine
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

9.  Legionnaires' disease: clinical features of 24 cases.

Authors:  B D Kirby; K M Snyder; R D Meyer; S M Finegold
Journal:  Ann Intern Med       Date:  1978-09       Impact factor: 25.391

10.  Antibiotic treatment of guinea-pigs infected with agent of Legionnaires' disease.

Authors:  D W Fraser; I Wachsmuth; C Bopp; J C Feeley; T F Tsai
Journal:  Lancet       Date:  1978-01-28       Impact factor: 79.321

View more
  26 in total

1.  High-Throughput Intracellular Antimicrobial Susceptibility Testing of Legionella pneumophila.

Authors:  Lucius Chiaraviglio; James E Kirby
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

2.  Legionella brain stem encephalopathy and peripheral neuropathy without preceding pneumonia.

Authors:  P D Heath; L Booth; P N Leigh; A M Turner
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-02       Impact factor: 10.154

3.  Legionnaires' disease: a review of 79 community acquired cases in Nottingham.

Authors:  M A Woodhead; J T Macfarlane
Journal:  Thorax       Date:  1986-08       Impact factor: 9.139

4.  In vitro activity of carumonam (Ro 17-2301; AMA-1080) versus enteropathogenic and nonfermentative gram-negative rods and Legionella pneumophila.

Authors:  P Hohl; A von Graevenitz; J Zollinger-Iten
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

5.  In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.

Authors:  T Barlam; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

6.  Susceptibilities of Legionella spp. to newer antimicrobials in vitro.

Authors:  T Schülin; C B Wennersten; M J Ferraro; R C Moellering; G M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

7.  Simple, transparent medium for study of legionellae.

Authors:  S R Johnson; W O Schalla; K H Wong; G H Perkins
Journal:  J Clin Microbiol       Date:  1982-02       Impact factor: 5.948

8.  [Legionella pneumophila pneumonia masked by simultaneous demonstration of further non-specific pneumonia pathogens].

Authors:  U Dickgiesser; H E Müller; G Böhm; D Fritsche
Journal:  Infection       Date:  1985 Sep-Oct       Impact factor: 3.553

9.  Comparative postantibacterial activities of pefloxacin, ciprofloxacin, and ofloxacin against intracellular multiplication of Legionella pneumophila serogroup 1.

Authors:  P Rajagopalan-Levasseur; E Dournon; G Dameron; J L Vilde; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

10.  Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.

Authors:  A Saito; K Sawatari; Y Fukuda; M Nagasawa; H Koga; A Tomonaga; H Nakazato; K Fujita; Y Shigeno; Y Suzuyama
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.